- Home
- CRDL vs RRGB Comparison
CRDL vs RRGB Comparison
Compare CRDL & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- RRGB
- Stock Information
- Founded
- CRDL 2017
- RRGB 1969
- Country
- CRDL Canada
- RRGB United States
- Employees
- CRDL N/A
- RRGB N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- RRGB Restaurants
- Sector
- CRDL Health Care
- RRGB Consumer Discretionary
- Exchange
- CRDL Nasdaq
- RRGB Nasdaq
- Market Cap
- CRDL 102.0M
- RRGB 91.6M
- IPO Year
- CRDL N/A
- RRGB 2002
- Fundamental
- Price
- CRDL $0.93
- RRGB $3.43
- Analyst Decision
- CRDL Strong Buy
- RRGB Strong Buy
- Analyst Count
- CRDL 3
- RRGB 4
- Target Price
- CRDL $9.00
- RRGB $11.88
- AVG Volume (30 Days)
- CRDL 241.3K
- RRGB 251.7K
- Earning Date
- CRDL 05-13-2025
- RRGB 02-26-2025
- Dividend Yield
- CRDL N/A
- RRGB N/A
- EPS Growth
- CRDL N/A
- RRGB N/A
- EPS
- CRDL N/A
- RRGB N/A
- Revenue
- CRDL N/A
- RRGB $1,248,560,000.00
- Revenue This Year
- CRDL N/A
- RRGB $1.24
- Revenue Next Year
- CRDL N/A
- RRGB N/A
- P/E Ratio
- CRDL N/A
- RRGB N/A
- Revenue Growth
- CRDL N/A
- RRGB N/A
- 52 Week Low
- CRDL $0.88
- RRGB $2.97
- 52 Week High
- CRDL $3.12
- RRGB $9.20
- Technical
- Relative Strength Index (RSI)
- CRDL 34.45
- RRGB 28.99
- Support Level
- CRDL $0.88
- RRGB $3.49
- Resistance Level
- CRDL $1.18
- RRGB $4.26
- Average True Range (ATR)
- CRDL 0.08
- RRGB 0.19
- MACD
- CRDL -0.01
- RRGB -0.05
- Stochastic Oscillator
- CRDL 21.54
- RRGB 10.38
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue.